Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 9/2019

Inhalt (23 Artikel)

Review – Cancer Research

Protective effect of the “food-microorganism-SCFAs” axis on colorectal cancer: from basic research to practical application

Han Shuwen, Da Miao, Qi Quan, Wu Wei, Zhang Zhongshan, Zhang Chun, Yang Xi

Original Article – Cancer Research

The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget’s disease

Giorgia Garganese, Frediano Inzani, Giulia Mantovani, Angela Santoro, Michele Valente, Gabriele Babini, Giuliana Petruzzellis, Simona Maria Fragomeni, Stefano Gentileschi, Sonia Bove, Massimo Franchi, Giuseppe Angelico, Anna Fagotti, Giovanni Scambia, Gian Franco Zannoni

Open Access Original Article – Cancer Research

Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells

Julian Böhm, Julienne Kathrin Muenzner, Aylin Caliskan, Benardina Ndreshkjana, Katharina Erlenbach-Wünsch, Susanne Merkel, Roland Croner, Tilman T. Rau, Carol Immanuel Geppert, Arndt Hartmann, Adriana Vial Roehe, Regine Schneider-Stock

Open Access Original Article – Cancer Research

Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis

Selina K. Sutton, Belamy B. Cheung, Hassina Massudi, Owen Tan, Jessica Koach, Chelsea Mayoh, Daniel R. Carter, Glenn M. Marshall

Original Article – Cancer Research

Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer

Sabine Heublein, Michael S. Anglesio, Frederik Marmé, Stefan Kommoss

Original Article – Cancer Research

Possible correlation of sonic hedgehog signaling with epithelial–mesenchymal transition in muscle-invasive bladder cancer progression

Koichi Kitagawa, Katsumi Shigemura, Shian-Ying Sung, Kuan-Chou Chen, Chao-Ching Huang, Yi-Te Chiang, Ming-Che Liu, Tzu-Wen Huang, Fukashi Yamamichi, Toshiro Shirakawa, Masato Fujisawa

Original Article – Cancer Research

REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression

Si Sun, Zhihuang Hu, Shenglin Huang, Xun Ye, Jialei Wang, Jianhua Chang, Xianghua Wu, Qifeng Wang, Lanlin Zhang, Xingjiang Hu, Hui Yu

Original Article – Cancer Research

Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC)

Jenny Hötzel, Nathaniel Melling, Julia Müller, Adam Polonski, Gerrit Wolters-Eisfeld, Jakob R. Izbicki, Karl-F. Karstens, Michael Tachezy

Original Article – Cancer Research

Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors

Sahyun Pak, Wansuk Kim, Yunlim Kim, Cheryn Song, Hanjong Ahn

Original Article – Clinical Oncology

Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma

Masaoki Ito, Yoshihiro Miyata, Shoko Hirano, Shingo Kimura, Fumiko Irisuna, Kyoko Ikeda, Kei Kushitani, Naoto Kishi, Yasuhiro Tsutani, Yukio Takeshima, Morihito Okada

Original Article – Clinical Oncology

Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?

Christian Guido Ruf, Stefan Borck, Petra Anheuser, Cord Matthies, Tim Nestler, Henrik Zecha, Hendrik Isbarn, Klaus-Peter Dieckmann

Original Article – Clinical Oncology

A randomized phase II, open-label and multicenter study of combination regimens of bortezomib at two doses by subcutaneous injection for newly diagnosed multiple myeloma patients

Feng Li, Fu-Sheng Yao, Xi-Jun Zhu, Wei-Ying Gu, Xiao-Hua Wang, Bing Chen, Dong-Ping Huang, Jia-Hua Ding, Tian-Qin Wu, Yan Zhu, Qian Zhao, Yu-Mei Tang, Ping Song, Xiao-Gang Zhou, Zhi-Ming An, Xing Guo, Xu-Li Wang, Long Zhong, Xiao-Bao Xie, Yong-Ping Zhai

Original Article – Clinical Oncology

Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study

Francois Ghiringhelli, Julie Vincent, Leila Bengrine, Christophe Borg, Jean Louis Jouve, Romaric Loffroy, Boris Guiu, Julie Blanc, Aurélie Bertaut

Original Article – Clinical Oncology

Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study

Alessandro Parisi, Alessio Cortellini, Michela Roberto, Olga Venditti, Daniele Santini, Emanuela Dell’Aquila, Marco Stellato, Paolo Marchetti, Mario Alberto Occhipinti, Federica Zoratto, Federica Mazzuca, Nicola Tinari, Michele De Tursi, Laura Iezzi, Clara Natoli, Margherita Ratti, Claudio Pizzo, Michele Ghidini, Giampiero Porzio, Corrado Ficorella, Katia Cannita

Original Article – Clinical Oncology

Impacts of thoracoscopic surgery and high grade histologic subtypes on spread through air spaces in small stage I lung adenocarcinomas

Tieniu Song, Lili Jiang, Zeguo Zhuo, Jun Luo, Guha Alai, Xu Shen, Yidan Lin

Original Article – Clinical Oncology

Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer

Qiang Zhou, Jiangbo Ren, Jinxuan Hou, Gang Wang, Lingao Ju, Yu Xiao, Yan Gong

Original Article – Clinical Oncology

Effects of surgery on survival of elderly patients with stage I small-cell lung cancer: analysis of the SEER database

Yan Li, Song Hu, Jun Xie, Xian Zhang, Yun Zong, Bin Xu, Chong Li

Letter to the Editor

Letter to the editors of the Journal of Cancer Research and Clinical Oncology

H. Matthes, R.-D. Hofheinz, G. Bar-Sela, D. Galun, D. Martin, R. Huber, J. Langhorts, P. F. Matthiessen, F. Schad

Letter to the Editors

Answer to the letter to the editors by Matthes and colleagues regarding our systematic reviews on mistletoe

Jutta Huebner, M. Freuding, C. Keinki, O. Micke, J. Buentzel

Correction

Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

Francesco Marampon, Flavio Leoni, Andrea Mancini, Ilaria Pietrantoni, Silvia Codenotti, Letizia Ferella, Francesca Megiorni, Giuliana Porro, Elisabetta Galbiati, Pietro Pozzi, Paolo Mascagni, Alfredo Budillon, Roberto Maggio, Vincenzo Tombolini, Alessandro Fanzani, Giovanni Luca Gravina, Claudio Festuccia

Neu im Fachgebiet Onkologie

Mit dem Alkoholentzug sinkt das Krebsrisiko

Wie die Ergebnisse einer Studie aus Frankreich nahelegen, kann sich das Risiko von alkoholabhängigen Menschen, an einem alkoholassoziierten Tumor zu erkranken, um rund 40% vermindern, wenn sie das Trinken reduzieren oder ganz einstellen.

Gemischte Befunde zur zielgerichteten Adjuvanz

23.07.2024 Melanom Nachrichten

Mit Blick auf rezidiv- und metastasenfreies Überleben bestätigen die finalen Ergebnisse der COMBI-AD-Studie die Wirksamkeit von Dabrafenib/Trametinib beim Stadium-III-Melanom. Die Effekte auf das Gesamtüberleben sind dagegen weniger klar.  

Verkürzte MRT bei dichtem Brustgewebe: Was bringen sequenzielle Scans?

21.07.2024 Mamma-MRT Nachrichten

Frauen mit dichtem Brustgewebe könnten zusätzlich zum regulären Mammografie-Screening von sequenziellen MRT-Untersuchungen mit verkürztem Protokoll (AB-MRT) profitieren, schlagen US-Radiologen vor.

Informierte Frauen neigen zu späterem Mammografie-Screening

Frauen in ihren 40ern, die über die Vor- und Nachteile des Mammografie-Screenings auf Brustkrebs informiert werden, neigen stärker dazu, den Screeningbeginn nach hinten zu verschieben. Die Mehrheit aber nähme das Angebot an, wie eine US-Studie zeigt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.